HOME >> MEDICINE >> NEWS
FINAL ALERT: RPB Science Writers Seminar in Eye Research to be held in Washington, DC Sept. 22-25

To: SCIENCE AND MEDICAL WRITERS, EDITORS AND BROADCASTERS
RPB'S SIXTEENTH NATIONAL SCIENCE WRITERS SEMINAR IN EYE RESEARCH AND VISION
THE ST. GREGORY HOTEL, WASHINGTON, DC
SUNDAY, SEPTEMBER 22 WEDNESDAY, SEPTEMBER 25, 2002

THE PROGRAM IS NOW SETand it's a beauty...a heady brew, a veritable Septemberfest, of scintillating science and first-rate storiescourtesy of the 30 and more top-rank, front-line investigators who'll be on hand to brief you on a remarkable string of recent gains against a host of vision-savaging ills. Needless to say, there'll be tons to file.

The Seminar will be held at the St. Gregory, a splendid, much-in-demand hostelry where space is always at a premium, has set a strict deadline for honoring reservations at our special rate ($169 + 14% room tax per night, single or double). So please do email tfurlong@rpbusa.org ASAP indicating that you would like to reserve a single or a double room and provide arrival and departure dates. If you plan to attend but do not need a hotel room, please also notify us at the same address so that your press kit, badge and other materials can be prepared.

************ PLEASE NOTE ************

FOLLOWING OUR TRADITIONAL WELCOME RECEPTION on Saturday evening, starting at 6:00 p.m., September 21, the sessions begin in earnest on Sunday afternoon, at 1:00 p.m., with a special mini-symposium: THE PEDIATRIC EYE. It will feature reports on: the latest wisdom regarding the development of near- and far-sightedness in children, what signs parents should look for and what measures to take; LASIK surgery to treat and ultimately prevent amblyopia ("lazy eye") in the pediatric population; latest findings from a trial designed to assess the benefits of intraocular lens implantation vs. contact lens therapy to correct vision in infants after surgery for congenital cataract; the latest word on the newly developed abilities to predict an
'"/>

Contact: Tom Furlong
tfurlong@rpbusa.org
800-621-0026
Research to Prevent Blindness
22-Aug-2002


Page: 1 2 3 4 5 6 7

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. 2005 Behavioral Sciences & Health Services Research Award
3. Innovation prize finalists announced in Science of Better
4. NIH panel issues State-of-the-Science statement on end-of-life care
5. 2004 Science-in-Society Award winners announced
6. Dec. 10-12 Japanese-American Frontiers of Science Meeting in Irvine, Calif.
7. GSA bestows Robert W. Kleemeier Award to University of Texas Health Science Centers Smith
8. Scripps atmospheric scientist appointed to Pontifical Academy of Sciences
9. Science of better convenes operations researchers in Denver
10. National Academies advisory: Nov. 4-6 Frontiers of Science meeting in Irvine, Calif.
11. Research news from the Friedman School of Nutrition Science and Policy at Tufts University

Post Your Comments:
(Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
(Date:4/17/2014)... first genetic variant specifically associated with the risk ... 10-15 per cent of all breast cancer cases. ... cancer sub-type, called invasive lobular carcinoma, gives researchers ... particular kind of breast cancer, which can be ... (Thursday) in the journal PloS Genetics , ...
(Date:4/17/2014)... published today in PLOS Pathogens , children who ... common can mount an immune response to infection with ... bouts of high fever and illness and partially control ... findings may help researchers develop future interventions that prevent ... , Each year, approximately 200 million cases of malaria ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
(Date:1/14/2014)... Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre partner ... Virginia is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is ... husband, Dr. Cole Taylor , are avid scuba divers. "As ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
Cached News: